InvestSMART

Little Green Pharma Ltd (ASX:LGP)

ALERT: Price-sensitive ASX Announcement for LGP
Current share price for LGP : $0.077 -0.043 (-35.83%)+
Announcement
Release
30 Apr 2025 9:46AM
Price at Release
$0.120
Full Release
download
Summary
Little Green Pharma Ltd (LGP) released its Quarterly Activities Report and Appendix 4C for the period ended 31 March 2024, highlighting strong operational and financial performance. The company reported a 35% increase in unaudited group revenue to $8.7 million for the quarter, driven by growth in both the Australian and European markets. LGP successfully launched multiple new products, expanded its partnerships, and maintained its position as a leading medicinal cannabis supplier in key international markets. Operational highlights include further penetration into the German market, continued expansion in Australia with increased prescriber numbers, and the successful commissioning of a new manufacturing suite. The company maintained a strong cash position of $5.8 million at quarter end and is focused on further cost optimization and driving revenue growth through new product launches and market development initiatives.
Key Points
  • Group revenue increased by 35% to $8.7 million for the quarter.
  • Growth was driven by both Australian and European markets.
  • Multiple new medicinal cannabis products were launched.
  • Continued market expansion in Germany and Australia.
  • Prescriber numbers in Australia continued to rise.
  • Commissioning of a new manufacturing suite was completed.
  • Strong cash position of $5.8 million as at 31 March 2024.
  • Focus on cost optimization and revenue growth strategies.
  • Development of new products and market expansion initiatives.
  • Company remains a leading supplier of medicinal cannabis internationally.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.